| P50 | author | Ralph B. D'Agostino Sr. | Q59209521 |
| | Ken-Ichiro Seino | Q96643709 |
| | Cristin Print | Q41646647 |
| P2093 | author name string | Wei Zhang | |
| | Eric D Routh | |
| | Haruka Wada | |
| | Guangxu Jin | |
| | Yong Lu | |
| | Lance D Miller | |
| | Jeff W Chou | |
| | Ashok K Pullikuth | |
| | Julia Chifman | |
| P2860 | cites work | T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy | Q41917657 |
| | BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 |
| | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab | Q45070125 |
| | Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade | Q46178232 |
| | The Dual Role of Bone Morphogenetic Proteins in Cancer | Q47163689 |
| | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| | The regulatory role of activating transcription factor 2 in inflammation | Q26823130 |
| | Immune escape mechanisms as a guide for cancer immunotherapy | Q27024502 |
| | Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial | Q27853359 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 |
| | A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia | Q28587867 |
| | Java Treeview--extensible visualization of microarray data | Q29547226 |
| | PANTHER: a library of protein families and subfamilies indexed by function | Q29547480 |
| | Open source clustering software | Q29547702 |
| | The immune contexture in human tumours: impact on clinical outcome | Q29620667 |
| | Rcor2 underexpression in senescent mice: a target for inflammaging? | Q34027119 |
| | Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation | Q34228652 |
| | Immune protection of the brain--efficient and delicate | Q34993053 |
| | GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers | Q35557782 |
| | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Q51768874 |
| | Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. | Q52587537 |
| | Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. | Q52718461 |
| | The Immune Landscape of Cancer. | Q52720878 |
| | Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. | Q53155856 |
| | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Q54618275 |
| | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. | Q55036914 |
| | Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). | Q55497366 |
| | Pan-cancer deconvolution of tumour composition using DNA methylation | Q56890466 |
| | The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer | Q57790346 |
| | KDM5 histone demethylases repress immune response via suppression of STING | Q58798780 |
| | Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells | Q60954868 |
| | The long noncoding RNA regulates inflammatory gene expression | Q64111244 |
| | Cold Tumors: A Therapeutic Challenge for Immunotherapy | Q64244484 |
| | LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade | Q89222358 |
| | WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers | Q91009739 |
| | T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection | Q91288610 |
| | Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer | Q91385882 |
| | Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers | Q91500362 |
| | Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy | Q35981245 |
| | The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance | Q36123893 |
| | Conservation of immune gene signatures in solid tumors and prognostic implications. | Q36200301 |
| | LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain | Q36529262 |
| | Robust enumeration of cell subsets from tissue expression profiles | Q36539395 |
| | Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 |
| | Transforming growth factor-beta and the immune response: implications for anticancer therapy | Q36944384 |
| | Dysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells | Q37020090 |
| | Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis | Q37164487 |
| | Causal analysis approaches in Ingenuity Pathway Analysis | Q37592031 |
| | Cancer-testis antigens: the current status on antigen regulation and potential clinical use. | Q37995200 |
| | Deciphering and reversing tumor immune suppression. | Q38124437 |
| | Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. | Q38622239 |
| | IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. | Q38709131 |
| | Bone morphogenetic protein 7 is associated with the nodal invasion of colon cancer | Q38719348 |
| | Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S. | Q38795520 |
| | Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy | Q38867762 |
| | Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy. | Q38893119 |
| | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair | Q38902578 |
| | Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy. | Q38904811 |
| | The movers and shapers in immune privilege of the CNS. | Q39090554 |
| | Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. | Q40031362 |
| | Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer | Q40328309 |
| | Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity | Q40944056 |
| | Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells | Q41369044 |
| | Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade | Q41596176 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P304 | page(s) | 57 | |
| P577 | publication date | 2020-02-13 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types | |
| P478 | volume | 11 | |